A survey of clinical labs across the U.S. shows a troubling reduction in testing volume due to the COVID-19 pandemic, with cancer and histology diagnostics hit particularly hard. The results are part of the Kalorama Clinical Lab Tracker, a survey that was conducted in the third week of April by Science and Medicine Group company Kalorama Information, a market research firm that specializes in IVD. The survey included representation by facilities of varying sizes. Overall, 59% reported a significant impact from the COVID-19 pandemic, and the impact was stronger for those based in larger institutions. Labs for Institutions of more than 1,000 employees, 67% of them reported a significant impact on lab operations.
Read the full article: Molecular Diagnostics Is Up, Other Test Volume Is Down, Kalorama Survey Finds //
Source: https://www.prnewswire.com/news-releases/molecular-diagnostics-is-up-other-test-volume-is-down-kalorama-survey-finds-301056813.html